Cargando…

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy

OBJECTIVE: To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists’ judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. METHODS: This was a prospective, observational, 12-week study in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuga, Atsushi, Otsubo, Tempei, Tsuji, Toshinaga, Hayashi, Shinji, Imagawa, Hideyuki, Fujikoshi, Shinji, Escobar, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455004/
https://www.ncbi.nlm.nih.gov/pubmed/31040680
http://dx.doi.org/10.2147/NDT.S195445
_version_ 1783409641931145216
author Kuga, Atsushi
Otsubo, Tempei
Tsuji, Toshinaga
Hayashi, Shinji
Imagawa, Hideyuki
Fujikoshi, Shinji
Escobar, Rodrigo
author_facet Kuga, Atsushi
Otsubo, Tempei
Tsuji, Toshinaga
Hayashi, Shinji
Imagawa, Hideyuki
Fujikoshi, Shinji
Escobar, Rodrigo
author_sort Kuga, Atsushi
collection PubMed
description OBJECTIVE: To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists’ judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. METHODS: This was a prospective, observational, 12-week study in patients who received duloxetine or a selective serotonin reuptake inhibitor. Patients were ≥20 years old, resided in Japan, and had at least moderate depression (Quick Inventory of Depressive Symptomatology ≥16) and at least moderate painful physical symptoms (Brief Pain Inventory-Short Form average pain ≥3). The main outcome in this post-hoc analysis was the HAM-D17 cutoff best corresponding with patients’ working ability according to the investigator’s judgment. Area under the receiver-operator curve was used to determine the time point with the strongest relationship between HAM-D17 and working ability. The optimal HAM-D17 cutoff was determined based on the maximum of sensitivity (true positive rate) minus ([1 minus specificity] [true negative rate]). For the evaluation of binary data, a mixed effects model with repeated measures analysis was used. RESULTS: For the estimation of the HAM-D17 cutoff, the area under the receiver-operator curve was maximal at 12 weeks, when a HAM-D17 score of 6 resulted in the best correspondence with working ability in the combined study population. At 12 weeks, a HAM-D17 score of 6 also resulted in the maximum predictive ability in each of the two treatment groups separately. For predicted working ability at 12 weeks, 52.7% of duloxetine-treated patients achieved the HAM-D17 cutoff of ≤6, whereas 48.5% of SSRIs-treated patients achieved HAM-D17 ≤6 (P=0.477). CONCLUSION: In this study of patients with major depressive disorder and painful physical symptoms, a HAM-D17 score ≤6 corresponded best with patients’ working ability. This finding is consistent with previous studies showing that a HAM-D17 cutoff of ≤7 may overestimate functional recovery from MDD.
format Online
Article
Text
id pubmed-6455004
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64550042019-04-30 Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy Kuga, Atsushi Otsubo, Tempei Tsuji, Toshinaga Hayashi, Shinji Imagawa, Hideyuki Fujikoshi, Shinji Escobar, Rodrigo Neuropsychiatr Dis Treat Original Research OBJECTIVE: To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists’ judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. METHODS: This was a prospective, observational, 12-week study in patients who received duloxetine or a selective serotonin reuptake inhibitor. Patients were ≥20 years old, resided in Japan, and had at least moderate depression (Quick Inventory of Depressive Symptomatology ≥16) and at least moderate painful physical symptoms (Brief Pain Inventory-Short Form average pain ≥3). The main outcome in this post-hoc analysis was the HAM-D17 cutoff best corresponding with patients’ working ability according to the investigator’s judgment. Area under the receiver-operator curve was used to determine the time point with the strongest relationship between HAM-D17 and working ability. The optimal HAM-D17 cutoff was determined based on the maximum of sensitivity (true positive rate) minus ([1 minus specificity] [true negative rate]). For the evaluation of binary data, a mixed effects model with repeated measures analysis was used. RESULTS: For the estimation of the HAM-D17 cutoff, the area under the receiver-operator curve was maximal at 12 weeks, when a HAM-D17 score of 6 resulted in the best correspondence with working ability in the combined study population. At 12 weeks, a HAM-D17 score of 6 also resulted in the maximum predictive ability in each of the two treatment groups separately. For predicted working ability at 12 weeks, 52.7% of duloxetine-treated patients achieved the HAM-D17 cutoff of ≤6, whereas 48.5% of SSRIs-treated patients achieved HAM-D17 ≤6 (P=0.477). CONCLUSION: In this study of patients with major depressive disorder and painful physical symptoms, a HAM-D17 score ≤6 corresponded best with patients’ working ability. This finding is consistent with previous studies showing that a HAM-D17 cutoff of ≤7 may overestimate functional recovery from MDD. Dove Medical Press 2019-04-05 /pmc/articles/PMC6455004/ /pubmed/31040680 http://dx.doi.org/10.2147/NDT.S195445 Text en © 2019 Kuga et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed
spellingShingle Original Research
Kuga, Atsushi
Otsubo, Tempei
Tsuji, Toshinaga
Hayashi, Shinji
Imagawa, Hideyuki
Fujikoshi, Shinji
Escobar, Rodrigo
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
title Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
title_full Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
title_fullStr Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
title_full_unstemmed Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
title_short Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
title_sort analysis of ham-d scores and working ability in an observational study of japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or ssri monotherapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455004/
https://www.ncbi.nlm.nih.gov/pubmed/31040680
http://dx.doi.org/10.2147/NDT.S195445
work_keys_str_mv AT kugaatsushi analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy
AT otsubotempei analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy
AT tsujitoshinaga analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy
AT hayashishinji analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy
AT imagawahideyuki analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy
AT fujikoshishinji analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy
AT escobarrodrigo analysisofhamdscoresandworkingabilityinanobservationalstudyofjapanesepatientswithmajordepressivedisorderandpainfulphysicalsymptomstreatedwithduloxetineorssrimonotherapy